Bruce leads Simon Kucher’s fast-growing Life Sciences division in Greater China.
Bruce has over 20 years of experience in the life sciences industry. He has advised pharmaceutical majors and biotechnology and medical technology companies on key strategic issues, ranging from corporate strategy and scenario planning to research and development and portfolio plans, new product launches, market access and pricing, reimbursement and tendering, commercial excellence, and innovations as well as organization transformation and change management.
He has experience across diverse therapeutic areas, including oncology, immunology, the central nervous system, cardiovascular, diabetes, nephrology, respiratory, ophthalmology, and rare diseases, and across key segments of the healthcare value chain. Building on his in-depth industry expertise and market insights, Bruce helps clients develop actionable strategies for achieving results with a long-lasting impact.
Bruce is recognized as a thought leader on key industry topics, with recent publications on medtech access trends, reimbursement listing outlooks, business model innovations, and globalization strategy.
Bruce earned his MBA from the University of Chicago, MSc in molecular biology from the University of Rochester, and BSc in biochemistry from Fudan University.